Second blood-linked vCJD case

suggests a bigger at-risk population

Written byPhilip Hunter
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Researchers in the United Kingdom have reported the country's second case of variant Creutzfeldt-Jakob Disease (vCJD) thought to be associated with blood transfusion. The patient involved had a different prion protein genotype than all other cases so-far identified, suggesting more people than previously thought may be susceptible.

The case, reported in The Lancet, involved a person known to have received blood transfusions from a donor who later developed clinical symptoms of vCJD. The person died of other causes, but was revealed to be carrying the disease upon autopsy.

All previous cases of vCJD, whatever the method of transmission, involved people homozygous for methionine (MM) at codon 129 of PRNP, the prion protein gene. According to a Finnish study, 42% of the UK population is MM homozygous, with 47% heterozygous methionine/valine (MV) and the remaining 11% homozygous for valine (VV).

Both the latter groups, 58% in total, have been considered resistant ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies